Patch reduces air leakage

Data from a new prospective randomised trial shows that TachoSil reduces intraoperative alveolar air leakage after lobectomy or segmentectomy by 43% compared to standard treatment. Included in the trial were 152 patients, and the results also suggest a positive effect on the hospitalisation period by reducing the amount and duration of air leaks. Patients treated with TachoSil had a mean time to discharge of 6.2 days, whereas patients treated with standard treatment spent 7.7 days in hospital on average.

The data was presented at the spring meeting of the European Society of Thoracic Surgeons (ESTS) in Cluj, Romania.